Considering that the HER2 mutation events and the sample size (1/12 in HNSC and 2/27 in BLCA) in this cohort were small, further investigations with expanded cohorts are needed to confirm our present findings. Here, ERBB2 is linked to bladder transitional cell carcinoma.